Actively Recruiting
Consumption of Anti-Inflammatory Effects of Aronia Berry in Patients With Chronic Obstructive Pulmonary Disease
Led by Amasya University · Updated on 2025-10-01
50
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the effects of consuming freeze-dried aronia berries alongside medical treatment in patients aged 50 to 80 with chronic obstructive pulmonary disease (COPD). The study focuses on measuring anti-inflammatory, respiratory, and biochemical markers to understand how aronia berries may impact these health parameters. It is a randomized, placebo-controlled, double-blind trial conducted at a hospital pulmonology clinic. Participants are randomly assigned to one of two groups: one group receives 30 grams of freeze-dried aronia powder daily, while the other receives a placebo powder, both for an 8-week period. The aronia and placebo powders are prepared to look and taste similar to maintain blinding. Dietary intake is monitored through food diaries, and participants undergo clinical evaluations at the start and end of the intervention. During the study, participants will provide demographic information and complete questionnaires about their health, physical activity, and diet. Researchers will perform lung function tests, body composition measurements, and biochemical blood analyses before and after the 8-week treatment. The primary outcomes include inflammatory markers such as C-Reactive Protein and various interleukins, as well as the COPD Assessment Test score. Safety and adherence will be monitored throughout the trial.
CONDITIONS
Brief Title
Effect of Aronia Berry Consumption on Inflammatory Parameters
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 50-80 years
- Diagnosed with COPD
- Not following a vegetarian or vegan diet
- Willing to consume the provided aronia berry (black chokeberry)
- Non-smokers
- Have signed the informed consent form
- Has not undergone endobronchial tube or valve surgery in the last two years.
You will not qualify if you...
- Presence of associated chronic inflammatory or rheumatic diseases
- Chronic infections that may create a prothrombotic state
- Chronic kidney disease (CKD)
- Malignancy
- Hereditary thrombophilia
- Essential thrombocythemia
- Diagnosed endocrine disorders
- Malabsorption disorders
- Allergy to any food or berry fruits
- Smoking
- Participants who did not sign the informed consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants consume either 30 g of freeze-dried aronia powder or placebo powder daily for 8 weeks while maintaining a food diary and undergoing clinical evaluations.
2 visits (baseline and end of treatment, in-person)
Trial Site Locations
Total: 1 location
1
Yedikule Göğüs Hastalıkları Hastanesi
Istanbul, Zeytinburnu, Turkey (Türkiye), 34020
Actively Recruiting
Research Team
B
Buse Sarıkaya, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here